Abstract
Diagnosis of Lyme disease is problematic and results in both overtreatment and mistreatment. Attention to epidemiology and physical findings will prevent inappropriate investigations and therapies. The disease has tropisms for specific tissues, and medical care should be tailored to the site and severity of infection.
Similar content being viewed by others
References
Steere AC. Lyme disease. N Engl J Med 2001;345:115–125.
Brown SL, Hansen SL, Langone JJ. Role of serology in the diagnosis of lyme disease. JAMA 1999;282:62–66.
Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with singledose doxycycline for the prevention of lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001;345:79–83.
Nichol G, Dennis DT, Steere AC, et al. Test-treatment strategies for patients suspected of having lyme disease: a cost-effectiveness analysis. Ann Int Med 1998;128:37–48.
Wormser GP, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of lyme disease. Clin Infect Dis 2000; 31(Suppl 1):1.
Wormser BP, Ramanathan R, Nowakowski J, et al. Duration of therapy for early lyme disease. Ann Int Med 2003;138:697–704.
Logigian EL, Kaplan RF, Steere AC. Successful treatment of lyme encephalopathy with intravenous ceftriaxone. J Infect dis 1999; 180:377–383.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have stated that he does not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. The author does not discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products or devices.
About this article
Cite this article
Weiner, H.R. Lyme disease. Compr Ther 32, 17–19 (2006). https://doi.org/10.1385/COMP:32:1:17
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/COMP:32:1:17